Back
ESC2025 Premium Access

Effects of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and an eGFR below 30 ml/min/1.73 m2

Session: Novel treatment approaches in heart failure and cardiomyopathies
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Speaker: Ms J. Locatelli Bet (Rio Do Sul, BR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Ms Julia Locatelli Bet

Rio Do Sul (Brazil)
0 follower

6 more presentations in this session

Impact of rhythm control in wild-type transthyretin cardiac amyloidosis and atrial fibrillation: a retrospective analysis

Speaker: Doctor J. Vogel (Essen, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Clinical features of chronic active myocarditis in patients with heart failure and reduced left ventricular ejection fraction

Speaker: Doctor M. Ruiz Cano (Bad Oeynhausen, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Apical sparing and clinical parameters in patients with histologically confirmed transthyretin amyloidosis

Speaker: Mr T. Krammer (Regensburg, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of GDMT implementation on albuminuria in HFrEF

Speaker: Doctor N. Panagiotides (Vienna, AT)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of tafamidis on sleep-disordered breathing in transthyretin cardiomyopathy

Speaker: Miss Y. Ferrari Chen (Pisa, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Novel treatment approaches in heart failure and cardiomyopathies

Speakers: Ms J. Locatelli Bet, Doctor J. Vogel, Doctor M. Ruiz Cano, Mr T. Krammer, Doctor N. Panagiotides...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources